Stuart J. Kahn

1.5k total citations
33 papers, 1.1k citations indexed

About

Stuart J. Kahn is a scholar working on Epidemiology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stuart J. Kahn has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 14 papers in Immunology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stuart J. Kahn's work include Trypanosoma species research and implications (22 papers), Research on Leishmaniasis Studies (11 papers) and Immune Cell Function and Interaction (10 papers). Stuart J. Kahn is often cited by papers focused on Trypanosoma species research and implications (22 papers), Research on Leishmaniasis Studies (11 papers) and Immune Cell Function and Interaction (10 papers). Stuart J. Kahn collaborates with scholars based in United States, South Africa and India. Stuart J. Kahn's co-authors include David D. Sherry, Carol A. Wallace, Malcolm S. Duthie, James W. French, Maria Kahn, Maria P. White, Karen Cowgill, Rhea N. Coler, Jill A. Ashman and Franco M. Piazza and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Stuart J. Kahn

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart J. Kahn United States	17	485	468	359	247	193	33	1.1k
Stanford T. Roodman United States	16	379 0.8×	80 0.2×	451 1.3×	139 0.6×	49 0.3×	37	1.0k
Márcia Martins Reis Brazil	14	439 0.9×	234 0.5×	142 0.4×	49 0.2×	60 0.3×	36	690
Yuka Torii Japan	16	394 0.8×	70 0.1×	175 0.5×	76 0.3×	72 0.4×	67	896
Yutaka Kubota Japan	17	184 0.4×	203 0.4×	50 0.1×	116 0.5×	397 2.1×	79	961
Carlos Vigliano Argentina	24	1.9k 3.9×	1.3k 2.9×	102 0.3×	178 0.7×	34 0.2×	66	2.3k
Narayanan Sathish India	18	479 1.0×	101 0.2×	137 0.4×	170 0.7×	18 0.1×	34	998
J. A. Bradley United Kingdom	15	111 0.2×	54 0.1×	232 0.6×	317 1.3×	86 0.4×	24	879
Yik Chun Wong Hong Kong	17	276 0.6×	142 0.3×	290 0.8×	488 2.0×	167 0.9×	42	1.1k
B Chiu Canada	13	301 0.6×	73 0.2×	287 0.8×	102 0.4×	35 0.2×	20	849
Faézeh Legrand France	19	521 1.1×	161 0.3×	164 0.5×	46 0.2×	64 0.3×	56	1.2k

Countries citing papers authored by Stuart J. Kahn

Since Specialization

Citations

This map shows the geographic impact of Stuart J. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Kahn more than expected).

Fields of papers citing papers by Stuart J. Kahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Kahn. The network helps show where Stuart J. Kahn may publish in the future.

Co-authorship network of co-authors of Stuart J. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Kahn. A scholar is included among the top collaborators of Stuart J. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Kahn. Stuart J. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Sapna P., Anastasios Dimou, Adrienne I. Victor, et al.. (2024). Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy.. Journal of Clinical Oncology. 42(16_suppl). 9508–9508. 10 indexed citations

Sallman, David A., Amy E. DeZern, Arlene A. Gayle, et al.. (2022). Phase 1 Results of the First-in-Class CXCR1/2 Inhibitor SX-682 in Patients with Hypomethylating Agent Failure Myelodysplastic Syndromes. Blood. 140(Supplement 1). 2070–2072. 11 indexed citations

Zebala, John A., Aaron D. Schuler, Stuart J. Kahn, & Dean Y. Maeda. (2020). Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist. Frontiers in Pharmacology. 10. 1680–1680. 12 indexed citations

Zebala, John A., et al.. (2019). Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials. Journal of Pain. 20(10). 1218–1235. 9 indexed citations

Zebala, John A., et al.. (2014). LD-Aminopterin in the Canine Homologue of Human Atopic Dermatitis: A Randomized, Controlled Trial Reveals Dosing Factors Affecting Optimal Therapy. PLoS ONE. 9(9). e108303–e108303. 2 indexed citations

Menter, Alan, Christina Cherian, Larry H. Matherly, et al.. (2012). Intestinal Transport of Aminopterin Enantiomers in Dogs and Humans with Psoriasis Is Stereoselective: Evidence for a Mechanism Involving the Proton-Coupled Folate Transporter. Journal of Pharmacology and Experimental Therapeutics. 342(3). 696–708. 15 indexed citations

Chakravarty, Jaya, Sonali Trivedi, Anup Singh, et al.. (2011). A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine. 29(19). 3531–3537. 120 indexed citations

Bao, Yi, Louis M. Weiss, Fen Yan, Stuart J. Kahn, & Huan Huang. (2010). Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi. Microbes and Infection. 12(10). 716–726. 20 indexed citations

Vélez, Iván Darío, José R. Ramírez‐Pineda, Jill A. Ashman, et al.. (2009). Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis. Vaccine. 28(2). 329–337. 61 indexed citations

10.

Duthie, Malcolm S., Martín S. Cetron, Wesley C. Van Voorhis, & Stuart J. Kahn. (2005). Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes. Acta Tropica. 93(3). 317–329. 6 indexed citations

11.

Duthie, Malcolm S. & Stuart J. Kahn. (2005). NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. International Immunology. 17(5). 607–613. 18 indexed citations

12.

Duthie, Malcolm S., Maria Kahn, Maria P. White, Raj P. Kapur, & Stuart J. Kahn. (2004). Critical Proinflammatory and Anti-Inflammatory Functions of Different Subsets of CD1d-Restricted Natural Killer T Cells during Trypanosoma cruzi Infection. Infection and Immunity. 73(1). 181–192. 73 indexed citations

13.

Duthie, Malcolm S. & Stuart J. Kahn. (2002). Treatment with α-Galactosylceramide Before Trypanosoma cruzi Infection Provides Protection or Induces Failure to Thrive. The Journal of Immunology. 168(11). 5778–5785. 29 indexed citations

14.

Kahn, Stuart J., et al.. (1999). The Surface Protein Superfamily of Trypanosoma cruzi Stimulates a Polarized Th1 Response That Becomes Anergic. The Journal of Immunology. 162(10). 6092–6099. 43 indexed citations

15.

Kahn, Stuart J., et al.. (1999). Trypanosoma cruzi:Monoclonal Antibodies to the Surface Glycoprotein Superfamily Differentiate Subsets of the 85-kDa Surface Glycoproteins and Confirm Simultaneous Expression of Variant 85-kDa Surface Glycoproteins. Experimental Parasitology. 92(1). 48–56. 18 indexed citations

16.

Flamme, Anne Camille La, Stuart J. Kahn, Alexander Y. Rudensky, & Wesley C. Van Voorhis. (1997). Trypanosoma cruzi‐infected macrophages are defective in major histocompatibility complex class II antigen presentation. European Journal of Immunology. 27(12). 3085–3094. 28 indexed citations

17.

Sherry, David D., Carol A. Wallace, & Stuart J. Kahn. (1996). Pediatric rheumatology in adult rheumatology practices in Washington state. Arthritis & Rheumatism. 39(7). 1218–1221. 16 indexed citations

18.

Cetron, Martín S., et al.. (1993). Humoral and Cellular Immune Response of Adults from Northeastern Brazil with Chronic Trypanosoma cruzi Infection: Depressed Cellular Immune Response to T. cruzi Antigen among Chagas' Disease Patients with Symptomatic Versus Indeterminate Infection. American Journal of Tropical Medicine and Hygiene. 49(3). 370–382. 38 indexed citations

19.

Kahn, Stuart J., et al.. (1993). SA85-1 proteins of Trypanosoma cruzi lack sialidase activity. Molecular and Biochemical Parasitology. 60(1). 149–152. 14 indexed citations

20.

Kahn, Stuart J., Maria Kahn, & Harvey Eisen. (1992). Polyreactive autoantibodies to negatively charged epitopes following Trypanosoma cruzi infection. European Journal of Immunology. 22(12). 3051–3056. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact